Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: The commercial agreement a contract for best effort performance, which was

All contracts are subject Bankruptcy Court purview and discretion, and generally the creditors committee will have significant input. As well, all assets (i.e. TPL's 50% MMP) are subject to the same purview and discretion. If it can be demonstrated that the stakeholders will be better off with MMP control/ownership held outside of TPL, then likely the asset, or control over it, will be transferred or sold. Even if forcing an auction for TPL's 50% results in an entity other than PTSC owning it, it may well still be in our benefit, as well as the other Ch11 stakeholders.

If the powers-that-be at PTSC concur, they have probably their single best opportunity (ever) to force the issue now.

Share
New Message
Please login to post a reply